BLA Regulatory Joins Maryland Trade Mission at BioJapan 2022 in Yokohama, Japan between 12-14 Oct.
Gaithersburg, MD (07 October 2022) – BLA Regulatory, LLC, a full-service biopharma regulatory consultancy, announced that BLA will attend BioJapan 2022 in Yokohama, Japan between 12-14 Oct. 2022. Welcome to stop by.
About BLA Regulatory, LLC
BLA Regulatory, LLC, is a full-service drug regulatory consultancy focusing on the US with global reach to other major markets. BLA provides comprehensive regulatory strategy and operation services from pre-IND strategic planning, IND preparation & submission, all the way to submission and approval of BLA/NDA. Our goal is to help moving your product through the development cycle efficiently. With experiences of 300+ INDs and 50+ NDAs/BLAs to our senior consultants, BLA brings clients a broad range of experiences from Big Pharma, CROs, and the FDA. Our services expand across regulatory, CMC, nonclinical, clinical, biostatistics, scientific writing, project management, eCTD publishing, and submission. We have extensive experience across therapeutic areas such as oncology, respiratory, addiction, autoimmune, inflammatory, metabolic, and cardiovascular diseases.
For further information contact:
Jiangang He, BD Dept.